secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001104659-25-076151
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve asset sale to Ninjour Health and merger-related charter amendments
--------------------------------------------------------------------------------

- Asset Sale to Ninjour Health International Ltd approved: 1,273,715 For, 26,206 Against, 2,305 Abstentions.
- Charter amendment for Vyome Therapeutics merger approved: 1,240,191 For, 58,555 Against, 3,480 Abstentions.
- Special Meeting reconvened on August 7, 2025 after adjournment on July 24, 2025 to vote on these proposals.
- Amendments to Article VI of Restated Certificate of Incorporation will take effect at merger close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925076151/0001104659-25-076151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925076151/tm2523158d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-076151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer